Important regulatory notice. This page is a research-context summary of the regulatory status of GHK-Cu in the United Kingdom. It is not legal or medical advice. Peptides Lab UK supplies research-use-only laboratory reference compounds. Products are not for human or veterinary use.
Quick summary. GHK-Cu is not a licensed medicine in the United Kingdom. The MHRA has not issued a marketing authorisation for any GHK-Cu product for systemic human use. Topical cosmetic products containing GHK-Cu at low concentration are sold as cosmetics under cosmetics regulation, where they make only cosmetic claims. Research-use-only GHK-Cu reference compounds are sold to the laboratory market and sit outside the medicines framework provided they are not marketed for human use.
The three regulatory contexts for GHK-Cu in the UK
Context 1: there is no MHRA-licensed GHK-Cu medicine for systemic human use. There is no NHS prescription pathway and there is no UK Summary of Product Characteristics for systemic GHK-Cu.
Context 2: cosmetic products containing GHK-Cu (typically at 0.05 to 3 percent) are widely sold under cosmetics regulation. These products are not medicines and may make only cosmetic claims.
Context 3: GHK-Cu sold as a research-use-only laboratory reference compound for in-vitro work and analytical chemistry sits outside the medicines framework provided it is not marketed for human use. This is the regulatory position Peptides Lab UK operates within.
Where the law tightens
Marketing GHK-Cu for human use, or making any therapeutic claim about it, brings the product inside the Human Medicines Regulations 2012, regardless of any ‘research-use-only’ label on the bottle. The MHRA position has been stated clearly: the label does not protect a seller who is in fact marketing for human use through claims, dosing tables or before-and-after content.
2026 UK enforcement context
The Guardian on 4 April 2026 reported that the MHRA had opened investigations into UK clinics making therapeutic claims about unregulated peptide products. The BBC has covered the same issue. UK retailers selling GHK-Cu with claims of efficacy for skin, hair, anti-ageing, wound healing or systemic use are operating outside the regulatory framework.
How Peptides Lab UK operates
We supply GHK-Cu as a research-use-only laboratory reference compound for in-vitro work and analytical chemistry, with batch-specific HPLC certificates of analysis. We do not market it for human or veterinary use. We do not publish dosing, administration or therapeutic guidance.
Frequently Asked Questions
Is GHK-Cu legal in the UK?
The molecule is not in itself prohibited. Cosmetic products containing GHK-Cu are legal as cosmetics. Research-use-only reference compounds are legal at the supply level provided they are not marketed for human use. There is no MHRA-licensed GHK-Cu medicine for systemic human use.
Can I buy GHK-Cu cosmetics legally in the UK?
Yes. Cosmetic products containing GHK-Cu at low concentration are widely sold by regulated cosmetic retailers.
Can I get GHK-Cu on prescription in the UK?
No. There is no MHRA-licensed GHK-Cu medicine for systemic human use.
Where can I read the regulator position?
The MHRA publishes guidance at gov.uk. The 4 April 2026 Guardian report is a useful summary of current enforcement direction.
Research use only. Peptides Lab UK supplies research-use-only laboratory reference compounds with batch-specific certificates of analysis. Products are not for human or veterinary use.
